Lisa LeCointe-Cephas - 03 May 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: SVP Chief Ethics & Com Officer
Signature: /s/ Kelly E. W. Grez as attorney-in-fact for Lisa LeCointe-Cephas
Issuer symbol: MRK
Transactions as of: 03 May 2023
Net transactions value: +$116,534
Form type: 4
Filing time: 05 May 2023, 17:01:15 UTC
Previous filing: 04 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRK	Common Stock	Options Exercise	$81,226	+689	+17%	$117.89	4,844	03 May 2023	Direct
transaction	MRK	Common Stock	Tax liability	$27,822	-236	-4.9%	$117.89	4,608	03 May 2023	Direct
transaction	MRK	Common Stock	Options Exercise	$96,113	+813	+18%	$118.22	5,421	04 May 2023	Direct
transaction	MRK	Common Stock	Tax liability	$32,983	-279	-5.1%	$118.22	5,142	04 May 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Restricted Stock Unit	Options Exercise	$0	-689	-33%	$0.000000	1,378	03 May 2023	Common Stock	689		Direct	F1, F2
transaction	MRK	Restricted Stock Unit	Options Exercise	$0	-813	-50%	$0.000000	816	04 May 2023	Common Stock	813		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024, and 5/3/2025.
F3	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.